Skip to main content
. 2010 Jun 21;2010:592760. doi: 10.1155/2010/592760

Table 1.

Body weight, lipid profile and blood pressure in the control and diabetic ZDF rats at the initial and final time (6 weeks of vehicle or sitagliptin treatment).

Initial Time (20 wks) Final Time (26 wks)

Control ZDF (+/+) Diabetic ZDF (fa/fa) Control ZDF (+/+) Diabetic ZDF (fa/fa)

Groups (n = 16) (n = 16) Vehicle (n = 8) Vehicle (n = 8) Sitagliptin (n = 8)
BW (g) 406.70 ± 6.83 388.10 ± 8.87 445.70 ± 8.16 354.40 ± 8.85aaa 380.00±14.46
Total-c (mg/dl) 77.50 ± 1.50 155.50 ± 3.50aaa 93.00 ± 2.96 193.00 ± 9.79aaa 193.10±4.62
TGs (mg/dl) 115.00 ± 11.00 374.50 ± 4.95a 154.00 ± 19.14 400.20 ± 27.00aaa 237.10 ± 22.54bbb
Systolic (mmHg) 115.50 ± 0.83 125.20 ± 0.27 116.00 ± 2.52 127.80 ± 1.23a 101.60 ± 0.78bbb
Diastolic (mmHg) 100.98 ± 0.82 91.46 ± 0.83 103.50 ± 1.94 112.70 ± 3.98 94.86 ± 0.70bbb
Mean (mmHg) 104.25 ± 0.25 108.20 ± 1.42 104.30 ± 4.25 117.40 ± 3.04a 96.86 ± 0.51bbb
Pulse P (mmHg) 14.52 ± 0.98 33.74 ± 0.37 14.00 ± 4.16 15.09 ± 3.08 6.71 ± 1.11b

BW, body weight; P, pressure; SITA, sitagliptin; Total-c, Total-cholesterol; TGs, triglycerides; ZDF, Zucker diabetic fatty. Values are means ± SEM of n rats. Comparisons between groups: a - ZDF (fa/fa) versus ZDF (+/+) and b - sitagliptin versus vehicle; P < .05, P < .01 and P < .001 for one, two or three letters, respectively.

HHS Vulnerability Disclosure